- £160.96m
- £179.47m
- £491.75m
- 90
- 97
- 41
- 91
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 26th | 2023 March 25th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 275 | 327 | 363 | 404 | 492 |
Cost of Revenue | |||||
Gross Profit | 122 | 138 | 148 | 150 | 184 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 250 | 300 | 341 | 381 | 462 |
Operating Profit | 24.9 | 27 | 21.9 | 22.1 | 29.6 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 24.7 | 25.8 | 21.1 | 21 | 27.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 20.2 | 20.4 | 17.3 | 15.6 | 21.6 |
Net Income Before Extraordinary Items | |||||
Net Income | 20.2 | 20.4 | 17.3 | 15.6 | 21.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 20.2 | 20.4 | 17.3 | 15.6 | 21.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.066 | 0.068 | 0.06 | 0.051 | 0.079 |
Dividends per Share |